Clinical Trials Administrator Archives – June 1, 2009
June 1, 2009
View Archives Issues
-
CT sites could learn a lot about community rapport from HIV trials
Few diseases have anywhere near the clout, exposure, and clinical trial support of HIV/AIDS. Dedicated foundations, advocacy groups, and international organizations have spent more than two decades working to ensure HIV prevention and medication trials are a top priority for governments and private industry. -
H1N1 outbreak should spur CT sites to prepare
As often happens with epidemics, the influenza A (H1N1) virus infection that began in Mexico in April started small, but jumped across the North American continent with breathtaking speed. -
GPP core principles would work for any clinical trial
Clinical trial professionals who would like guidelines for working with communities during study enrollment might look no further than the 10 fundamental principles created for HIV biomedical prevention research. -
Community boards help build local awareness
For many clinical trials developing a community advisory board (CAB) is the right thing to do for the local community and for eventual participants. But it's also the right strategy for investigators, who otherwise might miss cues about problems with their protocol design and participant education. -
HIV vaccine recruitment was aided by community outreach program
A clinical trial site enrolling for an HIV vaccine trial was successful in its strategies to engage and recruit from a local minority community, a new study shows. -
CT site successfully recruited minorities for HIV vaccine study
When a phase IIb clinical trial site needed to ensure minority enrollment in an HIV vaccine trial, CT staff and investigators tried a variety of successful methods to engage and educate the targeted community. -
Compliance Corner: Tight ship: CAPTN enlists IRB oversight
When they set out to create a research network to conduct clinical trials in the psychiatric care of children and adolescents, researchers at Duke University's Clinical Research Institute (DCRI) knew IRB issues would play a major role.